Use of home device for early detection of neovascular age-related macular degeneration.
Early treatment for choroidal neovascularization (CNV) is an important part of preserving visual function for patients with age-related macular degeneration. Preferential hyperacuity perimetry (PHP) provides high accuracy, sensitivity and specificity for detecting changes in lesions in diagnostic and treatment stages. The ForeseeHome is a PHP device designed for home use by patients. Regular use alerts retina specialists and patients of detected changes and allows patients to come in for visits when CNV begins or recurs. To maximize the benefit of recent breakthroughs in CNV treatment, patients should be better monitored with the ForeseeHome to detect new CNV while their vision is still good, and to promptly manage recurrence after treatment.
Department of Ophthalmology, Tel Aviv Medical Center, Sidney A Fox Chair in Ophthalmology, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. anatl@tlvmc.gov.il
Anat
A
Loewenstein
D000368:Aged; D000369:Aged, 80 and over; D020256:Choroidal Neovascularization / Q000175:diagnosis*; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D015203:Reproducibility of Results; D012648:Self Care / Q000379:methods*; D012680:Sensitivity and Specificity; D017216:Telemedicine; D014786:Vision Disorders / Q000175:diagnosis*; D058609:Visual Field Tests / Q000295:instrumentation*; D057135:Wet Macular Degeneration / Q000175:diagnosis*